NCT02040532View on ClinicalTrials.gov

Gabapentin for Insomnia Symptoms and Nighttime Vasomotor Symptoms (VMS) in Peri- and Postmenopausal Women

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
MenopauseHot FlashesVasomotor Disturbance
Interventions
DRUG

Gabapentin

The study is a 7-week intervention study using open-label gabapentin at bedtime with a scheduled dose titration from 100-mg for one week, followed by 300-mg for 3 weeks, and then 600-mg for 3 weeks.

Trial Locations (2)

02114

Massachusetts General Hospital, Boston

02116

Brigham and Women's Hospital, Boston

All Listed Sponsors
collaborator

Brigham and Women's Hospital

OTHER

collaborator

National Institute on Aging (NIA)

NIH

lead

Massachusetts General Hospital

OTHER

NCT02040532 - Gabapentin for Insomnia Symptoms and Nighttime Vasomotor Symptoms (VMS) in Peri- and Postmenopausal Women | Biotech Hunter | Biotech Hunter